ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2022

Oct 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2022-10-06

Reporting Person: RTW INVESTMENTS, LP (Director, 10% Owner, See Remarks)
Reporting Person: WONG RODERICK (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-06	Common Stock, $0.01 par value ("Common Stock")	P	1355932	$14.75	Acquired	17628567	Indirect

Footnotes

F1: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the shares of Common Stock held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.